National Postdoc Appreciation Week September 20-24, 2021
September 20-24 is National Postdoc Appreciation Week, and the NMD4C would like to take this time to recognize and celebrate the contributions of our postdoctoral members to the neuromuscular community. The scientific achievements, research, and discoveries from postdoctoral fellows advances our understanding of neuromuscular diseases, and the NMD4C are proud to support and empower our postdocs and other early-career members through our network’s activities.
- NMD4C and MDC postdoctoral research funding competition 2021
- WEBINAR: Setting up the Basics for a Successful Knowledge Translation Plan
Over the course of the appreciation week, we have highlighted some of the NMD4C’s incredible postdoctoral members conducting exciting research in the field of NMDs. Discover their profiles as a part of National Postdoc Appreciation Week!
Meet Some of the Postdoctoral Members of the NMD4C
Dr. Mo Zhao
Research Interests: Muscle disorders, Disease models, Zebrafish, Microscopy, Drug discovery
Discover Dr. Zhao’s research here.
Dr. Zhao’s PhD project involved the use of zebrafish and high-resolution microscopic techniques to study sarcomeric M-bands. In 2017, she joined Dr. James Dowling’s lab as a postdoctoral research fellow in the Department of Genetics & Genomic Biology at the Hospital for Sick Children in Toronto, Canada. She is currently working on zebrafish models of centronuclear myopathy with the aim of identifying therapeutic targets for pre/clinical trials.
Dr. Jean-Philippe Leduc-Gaudet
Research Interests: Skeletal muscle atrophy, Muscle disorders, Autophagy, Mitochondrial biology, Metabolic Complication
Discover Dr. Leduc-Gaudet’s research here.
Dr. Leduc-Gaudet completed his Ph.D. studying the regulatory roles of autophagy & mitophagy in the maintenance of skeletal muscle health under the supervision of Drs. Hussain and Gouspillou (McGill University), where he received a Vanier Canada Graduate Scholarship. In his research, Dr. Leduc-Gaudet combines genetic, molecular, cellular and physiological approaches to investigate signalling pathways regulating skeletal muscle mass and function. He is currently a postdoctoral fellow in Dr. Sandri’s lab (U Padova, Italy), working on characterizing novel genes and molecular pathways that control skeletal muscle health.
Dr. Marine Theret
Research Interests: Inflammation, Repair, Regeneration, Fibrosis
Discover Dr. Theret’s research here.
In 2016 Dr. Theret started her post-doctoral fellowship under the supervision of Dr. Fabio Rossi at the University of British Columbia. She now works on the cellular interactions between tissue resident mesenchymal stromal cells and the inflammatory milieu, which are primordial for skeletal muscle homeostasis, regeneration, and repair. Her research extends beyond the skeletal muscle tissue as it includes other inflammatory chronic diseases such as asthma or multiple sclerosis.
Dr. Kiran Polavarapu
Research Interests: Inherited Neuromuscular diseases, Neurogenetics, Next generation sequencing (NGS) analysis, Neuromuscular junction disorders, Primary Muscle disorders, Muscular dystrophies, Congenital myopathies
Discover Dr. Polavarapu’s research here.
Dr. Polavarapu’s PhD work involved developing next generation sequencing (NGS)-based tests for detection of both copy number variations and point mutations in Duchenne Muscular Dystrophy. He further worked on analysing NGS data and genotype-phenotype correlations of various inherited neuromuscular disorders in India including Limb-Girdle Muscular Dystrophy, congenital myopathies, hereditary neuropathies, and Congenital Myasthenic Syndrome. He recently joined the Lochmüller Lab as a postdoctoral fellow and is looking forward to continuing research in neuromuscular genetics and Congenital Myasthenic Syndrome.
If you are an early-career member or postdoc fellow interested in engaging with the NMD4C, we invite you to join us!
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.